Abstract

Methyl CpG binding protein-2 (MeCP2) is an essential epigenetic regulator in human brain development. Mutations in the MeCP2 gene have been linked to Rett syndrome, a severe X-linked progressive neurodevelopmental disorder, and one of the most common causes of mental retardation in females. MeCP2 duplication and triplication have also been found to affect brain development, indicating that both loss of function and gain in MeCP2 dosage lead to similar neurological phenotypes. Here, we used the Xenopus laevis visual system as an in vivo model to examine the consequence of increased MeCP2 expression during the morphological maturation of individual central neurons in an otherwise intact brain. Single-cell overexpression of wild-type human MeCP2 was combined with time-lapse confocal microscopy imaging to study dynamic mechanisms by which MeCP2 influences tectal neuron dendritic arborization. Analysis of neurons co-expressing DsRed2 demonstrates that MeCP2 overexpression specifically interfered with dendritic elaboration, decreasing the rates of branch addition and elimination over a 48 hour observation period. Moreover, dynamic analysis of neurons co-expressing wt-hMeCP2 and PSD95-GFP revealed that even though neurons expressing wt-hMeCP2 possessed significantly fewer dendrites and simpler morphologies than control neurons at the same developmental stage, postsynaptic site density in wt-hMeCP2-expressing neurons was similar to controls and increased at a rate higher than controls. Together, our in vivo studies support an early, cell-autonomous role for MeCP2 during the morphological differentiation of neurons and indicate that perturbations in MeCP2 gene dosage result in deficits in dendritic arborization that can be compensated, at least in part, by synaptic connectivity changes.

Highlights

  • Methyl-CpG binding protein 2 (MeCP2) is a DNA binding protein encoded by a gene located on chromosome Xq28 in humans, and is a protein that is evolutionarily conserved both in structure and in function

  • Our results show that a gain in MeCP2 function, achieved by the expression of wild-type human MeCP2 above the endogenous Xenopus MeCP2 expression, interfered with the morphological differentiation of tectal neuron dendritic arbors while simultaneously increased the formation of postsynaptic specializations on the few dendrites that developed and remained stable

  • Mutations in the MeCP2 gene, loss of gene function, as well as increased MeCP2 gene copy number have been associated with neurodevelopmental defects that lead to Rett syndrome and mental retardation [1,2,3,4,5]

Read more

Summary

Introduction

Methyl-CpG binding protein 2 (MeCP2) is a DNA binding protein encoded by a gene located on chromosome Xq28 in humans, and is a protein that is evolutionarily conserved both in structure and in function. Mutations in the Mecp gene have been linked to Rett syndrome in humans (RTT) [1], a severe X-linked progressive neurodevelopmental disorder and one of the most common causes of mental retardation in females. In addition to its role in formation and maturation of neuronal circuits, MeCP2 has been implicated in neuronal specification during early embryogenesis in several species, including Xenopus [6,7]. Studies show that MeCP2 can regulate neuronal precursor cell number by modulating transcription of the neuronal repressor xHairy in the differentiating neuroectoderm of early Xenopus embryos [6]. It is likely that in Xenopus, as in other vertebrate species, MeCP2 participates in both early and late aspects of central neuron development

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call